157 related articles for article (PubMed ID: 17984182)
1. Low incidence of isolated nodal failures after involved-field radiation therapy for non small-cell lung cancer: blinded by the light?
Jeremic B
J Clin Oncol; 2007 Dec; 25(35):5543-5. PubMed ID: 17984182
[No Abstract] [Full Text] [Related]
2. Involved-field radiation therapy for inoperable non small-cell lung cancer.
Rosenzweig KE; Sura S; Jackson A; Yorke E
J Clin Oncol; 2007 Dec; 25(35):5557-61. PubMed ID: 17984185
[TBL] [Abstract][Full Text] [Related]
3. Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in nonsmall cell lung cancer (NSCLC). Enough to convert no-elective into elective nodal irradiation (ENI)?
Jeremic B
Radiother Oncol; 2004 May; 71(2):123-5. PubMed ID: 15110444
[No Abstract] [Full Text] [Related]
4. Is there a definitive answer to the question of involved-field radiotherapy for inoperable non-small-cell lung cancer?
Lima CG; Cordova AL
J Clin Oncol; 2008 May; 26(13):2235; author reply 2235-6. PubMed ID: 18445859
[No Abstract] [Full Text] [Related]
5. Does incidental irradiation with doses below 50 gy effectively reduce isolated nodal failures in non-small-cell lung cancer: dose-response relationship.
Kepka L; Maciejewski B; Withers RH
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1391-6. PubMed ID: 19306748
[TBL] [Abstract][Full Text] [Related]
6. Thoracoscopic lobectomy with systemic lymph node dissection for lymph node positive non-small cell lung cancer--is thoracoscopic lymph node dissection feasible?
Shiraishi T; Hiratsuka M; Yoshinaga Y; Yamamoto S; Iwasaki A; Shirakusa T
Thorac Cardiovasc Surg; 2008 Apr; 56(3):162-6. PubMed ID: 18365976
[TBL] [Abstract][Full Text] [Related]
7. Postrecurrence survival in patients with stage I non-small cell lung cancer.
Nakagawa T; Okumura N; Ohata K; Igai H; Matsuoka T; Kameyama K
Eur J Cardiothorac Surg; 2008 Sep; 34(3):499-504. PubMed ID: 18579404
[TBL] [Abstract][Full Text] [Related]
8. Relation between elective nodal failure and irradiated volume in non-small-cell lung cancer (NSCLC) treated with radiotherapy using conventional fields and doses.
Sanuki-Fujimoto N; Sumi M; Ito Y; Imai A; Kagami Y; Sekine I; Kunitoh H; Ohe Y; Tamura T; Ikeda H
Radiother Oncol; 2009 Jun; 91(3):433-7. PubMed ID: 19167118
[TBL] [Abstract][Full Text] [Related]
9. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
[TBL] [Abstract][Full Text] [Related]
10. Time trends in nodal volumes and motion during radiotherapy for patients with stage III non-small-cell lung cancer.
Bosmans G; van Baardwijk A; Dekker A; Ollers M; Wanders S; Boersma L; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):139-44. PubMed ID: 17996384
[TBL] [Abstract][Full Text] [Related]
11. Involved-field radiotherapy is effective for patients 70 years old or more with early stage non-small cell lung cancer.
Yu HM; Liu YF; Yu JM; Liu J; Zhao Y; Hou M
Radiother Oncol; 2008 Apr; 87(1):29-34. PubMed ID: 18237795
[TBL] [Abstract][Full Text] [Related]
12. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
[TBL] [Abstract][Full Text] [Related]
13. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
Varlotto JM; Recht A; Nikolov M; Flickinger JC; Decamp MM
Cancer; 2009 Feb; 115(4):851-8. PubMed ID: 19140203
[TBL] [Abstract][Full Text] [Related]
14. Advances in radiotherapy for lung cancer.
Decker RH; Wilson LD
Semin Respir Crit Care Med; 2008 Jun; 29(3):285-90. PubMed ID: 18506666
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
[TBL] [Abstract][Full Text] [Related]
16. Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.
Bauman JE; Mulligan MS; Martins RG; Kurland BF; Eaton KD; Wood DE
Ann Thorac Surg; 2008 Nov; 86(5):1632-8; discussion 1638-9. PubMed ID: 19049763
[TBL] [Abstract][Full Text] [Related]
17. Preoperative radiation therapy for non-small cell lung cancer--alternative staging device.
Toole AL; Knowlton AH; Stern H
Conn Med; 1992 Aug; 56(8):415-20. PubMed ID: 1326425
[No Abstract] [Full Text] [Related]
18. Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.
Zhong W; Yang X; Bai J; Yang J; Manegold C; Wu Y
Eur J Cardiothorac Surg; 2008 Jul; 34(1):187-95. PubMed ID: 18457958
[TBL] [Abstract][Full Text] [Related]
19. Predictors of subclinical nodal involvement in clinical stages I and II non-small cell lung cancer--why change the study objectives? Regarding Sawyer et al. IJROBP 43(5):965-970; 1995.
Beitler JJ
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):830. PubMed ID: 10524443
[No Abstract] [Full Text] [Related]
20. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
